← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Arbutus Biopharma ABUS $850M	71	+21	+42%	$158M
52	SIOX 52 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	71	-10	-12%	$25.8M
53	ATNX 53 DELISTED Athenex, Inc. Common Stock ATNX	67	+4	+6%	$245M
54	54 Fortress Biotech FBIO $63.7M	65	-1	-2%	$22.9M
55	AGTC 55 DELISTED Applied Genetic Technologies Corporation AGTC	64	+10	+19%	$32.6M
56	56 Solid Biosciences SLDB $615M	64	+6	+10%	$616M
57	57 Cartesian Therapeutics RNAC $199M	57	-2	-3%	$144M
58	58 DELISTED BioLife Solutions BLFS	49	+19	+63%	$51.9M
59	59 Autolus Therapeutics AUTL $458M	48	+48	–	$241M
60	60 Cibus CBUS $98.6M	47	+8	+21%	$172M
61	61 ARK Genomic Revolution ETF ARKG $2.09B	46	+6	+15%	$33.5M
62	62 DELISTED Carisma Therapeutics CARM	46	+19	+70%	$78.2M
63	63 Adicet Bio ACET $48.1M	45	+6	+15%	$108M
64	HTGM 64 DELISTED HTG Molecular Diagnostics, Inc. Common Stock HTGM	44	+3	+7%	$45.6M
65	65 Neurogene NGNE $479M	44	-6	-12%	$46.2M
66	66 DELISTED BRAINSTORM CELL THERAPUTC BCLI	39	+5	+15%	$9.49M
67	67 Mustang Bio MBIO $2.93M	36	+15	+71%	$17.9M
68	68 Pluri PLUR $11.9M	35	0	0%	$4.89M
69	ONCS 69 DELISTED OncoSec Medical Incorporated ONCS	34	-4	-11%	$18.9M
70	70 DELISTED NeuBase Therapeutics, Inc. Common Stock NBSE	33	-2	-6%	$1.05M
71	71 Ocugen OCGN $276M	29	+1	+4%	$33.5M
72	72 Opus Genetics IRD $337M	27	+1	+4%	$2.58M
73	73 Marker Therapeutics MRKR $15.3M	27	+16	+145%	$14.1M
74	74 ProQR Therapeutics PRQR $205M	25	0	0%	$80.8M
75	75 MeiraGTx Holdings MGTX $950M	23	+23	–	$74.6M